|
DK590288D0
(da)
|
1988-10-24 |
1988-10-24 |
Symbicom Ab |
Kemiske forbindelser
|
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
US4376110A
(en)
|
1980-08-04 |
1983-03-08 |
Hybritech, Incorporated |
Immunometric assays using monoclonal antibodies
|
|
SE8205892D0
(sv)
|
1982-10-18 |
1982-10-18 |
Bror Morein |
Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
EP0154316B1
(en)
|
1984-03-06 |
1989-09-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified lymphokine and production thereof
|
|
SE8405493D0
(sv)
|
1984-11-01 |
1984-11-01 |
Bror Morein |
Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
|
|
US4877612A
(en)
|
1985-05-20 |
1989-10-31 |
Frank M. Berger |
Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
|
|
DE3521994A1
(de)
|
1985-06-20 |
1987-01-02 |
Bayer Ag |
N-(2-aminoacylamido-2-desoxy-hexosyl)-amide-, -carbamate und -harnstoffe, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
|
|
ES2039229T3
(es)
|
1986-01-14 |
1993-09-16 |
De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur |
Procedimiento para la preparacion de complejos inmunogenicos y composiciones farmaceuticas que contienen estos complejos.
|
|
US4806352A
(en)
|
1986-04-15 |
1989-02-21 |
Ribi Immunochem Research Inc. |
Immunological lipid emulsion adjuvant
|
|
US5777095A
(en)
|
1988-10-24 |
1998-07-07 |
Symbicom Aktiebolag |
Osp A and B Sequence of Borrelia burgdonferi strains ACA1 and IP90
|
|
US6143872A
(en)
|
1988-10-24 |
2000-11-07 |
Symbicom Aktiebolag |
Borrelia burdorferi Osp A and B proteins and immunogenic peptides
|
|
US7094391B1
(en)
|
1988-10-24 |
2006-08-22 |
The University Of Texas System |
Compositions and methods for administering Borrelia burgdorferi antigens
|
|
EP0401384B1
(en)
|
1988-12-22 |
1996-03-13 |
Kirin-Amgen, Inc. |
Chemically modified granulocyte colony stimulating factor
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5252714A
(en)
|
1990-11-28 |
1993-10-12 |
The University Of Alabama In Huntsville |
Preparation and use of polyethylene glycol propionaldehyde
|
|
DK0571538T5
(da)
|
1991-02-15 |
2002-03-04 |
Uab Research Foundation |
Strukturgen for pneumokokprotein
|
|
JPH07501687A
(ja)
|
1991-08-15 |
1995-02-23 |
スミスクライン・ビーチャム・バイオロジカルス（ソシエテ・アノニム） |
ボレリア・ブルグドルフェリのサブグループのｏｓｐ ａ 蛋白、それをコードしている遺伝子およびワクチン
|
|
US6676942B1
(en)
|
1991-08-15 |
2004-01-13 |
Smithkline Beecham Biologicals (S.A.) |
Osp a proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines
|
|
US5234784A
(en)
|
1992-04-01 |
1993-08-10 |
Eastman Kodak Company |
Method of making a projection viewable transparency comprising an electrostatographic toner image
|
|
PT726955E
(pt)
|
1993-11-01 |
2004-08-31 |
Brookhaven Science Ass Llc |
Proteinas quimericas compreendendo polipeptidos borrelia: suas utilizacoes
|
|
US7008625B2
(en)
|
1993-11-01 |
2006-03-07 |
Research Foundation Of The State University Of New York |
Recombinant constructs of Borrelia burgdorferi
|
|
US6248562B1
(en)
|
1993-11-01 |
2001-06-19 |
Research Foundation State University Of New York |
Chimeric proteins comprising borrelia polypeptides and uses therefor
|
|
EP0880360B1
(en)
|
1996-02-12 |
2002-10-09 |
Cobra Therapeutics Limited |
Novel methods of vaccination and vaccines therefore comprising a nucleic acid encoding a first epitope and a peptide containing a second epitope
|
|
US6342220B1
(en)
|
1997-08-25 |
2002-01-29 |
Genentech, Inc. |
Agonist antibodies
|
|
GB9726555D0
(en)
|
1997-12-16 |
1998-02-11 |
Smithkline Beecham Plc |
Vaccine
|
|
GB9811219D0
(en)
|
1998-05-26 |
1998-07-22 |
Smithkline Beecham Biolog |
Novel process
|
|
US6592875B1
(en)
*
|
1999-06-21 |
2003-07-15 |
Milkhaus Laboratory, Inc. |
Method for treatment of lyme disease
|
|
US6689364B2
(en)
|
2000-03-21 |
2004-02-10 |
Tufts University |
Borrelia burgdorferi polypeptides and uses thereof
|
|
WO2002016421A2
(en)
|
2000-08-18 |
2002-02-28 |
Research Foundation Of The State University Of New York |
Altered ospa of borrelia burgdorferi
|
|
EP1939294A1
(en)
|
2000-08-18 |
2008-07-02 |
Research Foundation Of State University Of New York |
Recombinant constructs of borrelia burgdorferi
|
|
DK1311682T3
(da)
|
2000-08-18 |
2008-05-05 |
Univ New York State Res Found |
Rekombinante konstruktioner af Borrelia burgdorferi
|
|
US8821893B2
(en)
|
2004-07-02 |
2014-09-02 |
Bio Peptides, Corp. |
Oral vaccine for Borrelia
|
|
WO2008101667A1
(en)
|
2007-02-22 |
2008-08-28 |
Baxter International Inc. |
Method of purification of hydrophobic proteins
|
|
EP2274616A1
(en)
|
2008-04-22 |
2011-01-19 |
The Research Foundation of State University of New York |
Borrelia burgdorferi cell envelope protein array
|
|
US20110262475A1
(en)
|
2008-05-02 |
2011-10-27 |
Earnhart Christopher G |
Lyme disease vaccine
|
|
EP3705133B1
(en)
|
2010-05-14 |
2024-06-26 |
Baxalta Incorporated |
Ospa chimeras and use thereof in vaccines
|